Endometrial cells undergo two distinct forms of senescence that differentially impact female fertility. Normal cyclical senescence supports healthy reproductive function by enhancing embryo implantation receptivity, while pathological excessive senescence triggered by external stimuli creates a cascade of cellular dysfunction that impairs fertility outcomes. Unlike age-related senescence, this pathological process can spread between cells and resist immune clearance mechanisms. This distinction represents a paradigm shift in understanding fertility decline. Rather than viewing reproductive aging as an inevitable consequence of chronological time, these findings suggest that environmental factors drive a reversible form of cellular senescence in the endometrium. The therapeutic implications are profound—senolytic interventions that selectively target pathologically senescent cells could restore fertility without disrupting normal reproductive cycles. This challenges the traditional fatalistic view of age-related fertility decline and opens new avenues for preserving reproductive function. However, the clinical translation remains complex, requiring precise targeting to avoid disrupting beneficial cyclical senescence while eliminating pathological cellular aging.